<-- test --!> Health and Fitness – Page 602 – Best Reviews By Consumers

Health and Fitness

Heike Prinz appointed to Board of Management of Bayer AG

Leverkusen, August 21, 2023 – The Supervisory Board of Bayer AG has unanimously appointed Heike Prinz to Bayer’s Board of Management effective September 1, 2023. She will become the company’s Chief Talent Officer and Labor Director. This follows the mutual agreement by Board member Sarena Lin and Bayer’s Supervisory Board to not extend her contract …

Heike Prinz appointed to Board of Management of Bayer AG Read More »

Marcus Jordan Says His Dad Will Be His Best Man, Despite That Beef With Larsa Pippen

Michael Jordan might not be thrilled that his son Marcus is in a relationship with Larsa Pippen, but Marcus is optimistic that his old man will come around. During a recent conversation on the Pablo Torres Finds Out podcast, Marcus announced his plans to have Michael as his best man, should he and Larsa end …

Marcus Jordan Says His Dad Will Be His Best Man, Despite That Beef With Larsa Pippen Read More »

ACS: Millions More Should Get Lung Cancer Screening

The American Cancer Society (ACS) widened the pool of past and current smokers eligible for lung cancer screening in its new guideline recommendations, potentially opening the door to 5 million more U.S. adults. Annual lung cancer screening with low‐dose CT is strongly recommended for asymptomatic patients ages 50 to 80 years who either currently smoke, …

ACS: Millions More Should Get Lung Cancer Screening Read More »

Fecal Transplants in Kidney Recipients Reduced Resistant Pathogens

In the single-center PREMIX clinical trial, most renal transplant recipients were negative for multidrug-resistant pathogens shortly after receiving fecal microbiota transplants (FMT), with longer times to recurrent infections. Eight of 10 participants who received a least one FMT, and eight of nine participants who received all FMT treatments were multidrug-resistant organism (MDRO) negative by day …

Fecal Transplants in Kidney Recipients Reduced Resistant Pathogens Read More »

Situs Inversus Cases Rise After China Lifts Zero-COVID Policy

There was a “striking increase” in the number of cases of fetal situs inversus at two Chinese obstetric centers after the zero-COVID policies were lifted in the country, researchers reported. From January through July of this year, the incidence of situs inversus — a rare congenital condition in which visceral organs are reversed from their …

Situs Inversus Cases Rise After China Lifts Zero-COVID Policy Read More »

Thalidomide Reduced Episodes of Recurrent GI Bleeding

Treatment with thalidomide led to a reduction in bleeding among patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), a randomized trial showed. In 150 patients, 68.6% of those who received 100-mg thalidomide daily for 4 months experienced a reduction of 50% or more in bleeding episodes in the year after treatment compared with 51% …

Thalidomide Reduced Episodes of Recurrent GI Bleeding Read More »

Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC

A reduced-dose schedule of cabazitaxel (Jevtana) plus prophylactic granulocyte colony-stimulating factor (G-CSF) should be offered to older men with metastatic castration-resistant prostate cancer (mCRPC), according to results from the phase III randomized CABASTY trial. Rates of grade 3 or higher neutropenia or neutropenic complications were about 12 times lower with biweekly cabazitaxel 16 mg/m2 plus …

Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC Read More »

Aflibercept 8 mg first to achieve sustained vision gains with more than 70% of patients extended to intervals between 16 and 24 weeks in wet age-related macular degeneration at two years

10 August 2023 | 12:59 PM Europe/Amsterdam Not intended for U.S. and UK Media – Two-year topline results from the pivotal study PULSAR: Summary Results from PULSAR demonstrate long term efficacy of aflibercept 8 mg with extended dosing intervals reaching up to 24 weeks and vision improvements comparable to Eylea™ (aflibercept 2 mg) at fixed …

Aflibercept 8 mg first to achieve sustained vision gains with more than 70% of patients extended to intervals between 16 and 24 weeks in wet age-related macular degeneration at two years Read More »